📞 022 4302 0000contact@takemyinsurance.com
Register|LoginJoin us as POSP
AboutWhat Is CoveredOffering TypesInsured PartiesWho Needs ItClaim ProcessExclusionsFAQsGet Quote Page Progress  0%
📈 Financial Liabilities Insurance · Capital Markets · IPO Insurance · Securities Liability · Prospectus Liability · SEBI · Transaction-Specific

Public Offering of Securities Insurance (POSI) — IPO & Prospectus Liability Cover for Directors, Officers, Underwriters & the Company —
Prospectus Liability · Defence Costs · Selling Shareholder · Underwriter Exposure · IPO · QIP · FPO · Up to 6 Years

India's capital markets boom has made IPOs larger, faster, and more complex — and investor scrutiny of prospectuses has never been more intense. Signatories of a public prospectus carry personal liability for every representation it contains. A single misrepresentation or omission can trigger investor class actions, SEBI enforcement, and personal liability for directors and officers that survives the transaction by years. POSI ring-fences this securities exposure in a single-premium, transaction-specific policy that protects the company, its directors, officers, underwriters, and selling shareholders for up to six years from the offering date.

✓ Prospectus Liability ✓ Directors & Officers Defence ✓ Underwriter Exposure ✓ Selling Shareholder Liability ✓ Defence Costs ✓ Up to 6 Years Coverage
IPO Companies · FPO / QIP Issuers · Lead Managers · Underwriters · Selling Shareholders · Private Equity Exits · Pre-IPO Investors  |  IRDAI Licensed Broker — Lic. No. 528
POSI
🏛IRDAI Licensed Broker · Lic. No. 528 · the insurer POSI
📈Prospectus Liability · Defence Costs · Underwriter Exposure · Selling Shareholder · IPO · FPO · QIP · Up to 6 Years
💵Companies Going Public · Lead Managers · Underwriters · PE / VC Exit Investors · Selling Promoters
📞POSI / IPO Insurance Enquiry 022 4302 0000
An IRDAI Licensed Insurance Broker

Financial Liabilities Insurance · Capital Markets · Securities Liability · Prospectus Liability · IPO · FPO · QIP · Private Placement

What Is Public Offering of Securities Insurance (POSI)?

Public Offering of Securities Insurance (POSI) — also known as IPO Insurance — is a transaction-specific, single-premium liability policy that protects the issuing company, its directors, officers and employees, underwriters, and selling shareholders against securities claims arising from a public or private offering of the company's securities. Unlike annual D&O policies that carry ongoing premium costs and aggregate across multiple policy years, POSI is placed once at the time of the offering, pays a single premium, and provides protection for a defined period of up to six years — precisely ring-fencing the prospectus liability window and protecting the company's existing D&O programme from being eroded by securities offering claims.

📈

Why India's Capital Markets Boom Has Made POSI Essential

  • India's IPO market is at a historic high — and so is investor scrutiny:India's primary market raised over ₹1.6 lakh crore through IPOs in FY2024–25 alone — a new record. With retail investor participation growing rapidly (over 9 crore demat accounts as of 2025), investor awareness of prospectus rights and securities litigation has grown correspondingly. SEBI's investor grievance redressal framework and the increasing sophistication of institutional investors have made prospectus scrutiny more intense than at any prior point in Indian capital market history.
  • Prospectus signatories carry personal liability for every representation:Under the Companies Act 2013 and SEBI (ICDR) Regulations, every person who signs a prospectus — including each director, the CFO, the CEO, and in some cases legal counsel and bankers — carries personal liability for misleading statements, omissions, and untrue representations in that prospectus. This personal liability is distinct from and additional to the company's liability. A director signing a prospectus is personally on the hook for investor losses traceable to any material misrepresentation — regardless of whether they personally prepared that section of the prospectus.
  • Securities claims arise years after the IPO — long-tail risk:Investor litigation following a prospectus is not limited to the immediate post-listing period. Securities claims can arise months or years after the IPO — when post-listing financial performance reveals that representations in the prospectus were inaccurate or that material information was omitted. SEBI enforcement actions, stock exchange investor grievance proceedings, National Company Law Tribunal (NCLT) proceedings, and civil court claims can all emerge from the same offering long after the company has moved on. The POSI policy period of up to six years specifically addresses this long-tail securities liability risk.
  • Standard D&O policies are inadequate and can be eroded by IPO claims:While companies typically carry Directors & Officers (D&O) insurance, standard annual D&O policies have significant limitations for securities offering scenarios: they do not typically provide the underwriter-specific coverage needed; they do not explicitly address all forms of prospectus liability; and critically, a large securities class action arising from an IPO can deplete the entire D&O policy limit, leaving the company's directors exposed for all other D&O claims during that policy year. POSI ring-fences the IPO-specific securities exposure, protecting the D&O policy for its intended purpose.
  • Premium can be capitalised against offer proceeds:A significant commercial advantage of POSI is that accounting rules may allow the POSI premium to be capitalised against the offering proceeds — treating it as a cost of the capital-raising transaction rather than as a profit-and-loss deduction. This means the insurance cost appears on the balance sheet as a transaction cost (similar to investment banking fees and listing costs) rather than reducing the company's reported profit, making POSI commercially and financially attractive relative to other forms of post-IPO risk management.
Key Features of POSI
📋

Prospectus Liability

Core coverage for actual or alleged untrue, misleading, or incomplete statements in the offering prospectus — protecting the company and all signatories against investor claims arising from prospectus misrepresentations or omissions, whether in the main prospectus, supplementary documents, or road show materials.

PROSPECTUS
👥

Directors & Officers Defence

Covers defence costs and settlements for each individual director, officer, and employee named in or connected to the offering — providing personal protection for IPO signatories who bear personal liability for prospectus contents under the Companies Act 2013 and SEBI regulations.

D&O
🏛

Underwriter Exposure

Covers the underwriters (investment banks, merchant bankers acting as book-running lead managers — BRLMs) for their exposure from actual or alleged untrue or misleading statements in the prospectus — essential for the banks that conduct due diligence and sign the offering document.

UNDERWRITER
⚖️

Selling Shareholder Liability

Covers controlling shareholders and selling shareholders (promoters, PE/VC investors exiting through the IPO OFS component) for their liability arising from actual or alleged untrue or misleading prospectus representations — critical for PE-backed IPOs with significant Offer for Sale components.

SELLING SH.
📈

Up to 6-Year Policy Period

POSI is transaction-specific — placed once at the time of the offering — with a customisable policy period of up to six years, reflecting the long-tail nature of securities litigation where investor claims can arise years after the IPO date when post-IPO performance reveals alleged prospectus misrepresentations.

6 YEARS
💵

Punitive & Exemplary Damages

POSI covers not only compensatory damages (investor losses from prospectus misrepresentation) but also punitive and exemplary damages where awarded by courts or tribunals — providing comprehensive financial protection for the full range of potential securities claim awards.

PUNITIVE

Coverage Scope — Prospectus Liability, Defence Costs, Underwriter & Shareholder Exposure

What POSI Covers in Detail

POSI provides comprehensive coverage for all the major financial exposures arising from a securities offering — from the immediate defence costs of responding to a regulatory inquiry through to multi-year securities litigation settlements.

📋

Prospectus Liability — The Core Coverage

The central coverage of POSI is protection against securities claims arising from the prospectus — the legal document filed with SEBI, the Registrar of Companies (RoC), and the stock exchanges that forms the basis of the public offering.

What constitutes a covered prospectus claim:
Untrue statements: A statement in the prospectus that was materially incorrect at the time of the offering — whether about the company's financial condition, business prospects, risk factors, litigation, related-party transactions, or use of proceeds
Misleading statements: Statements that were technically accurate but presented in a manner that created a false impression — including through selective disclosure, misleading context, or material omissions that made accurate statements misleading
Omissions: Material information that was required to be disclosed in the prospectus but was not included — SEBI (ICDR) Regulations prescribe extensive mandatory disclosure requirements; any significant omission creates prospectus liability
Road show and marketing materials: POSI can extend to cover liability arising from statements made in road show presentations, analyst briefings, and other marketing materials connected to the offering
Negotiations and discussions: POSI can cover liabilities arising from negotiations, discussions, and decisions made in connection with the offering process — including pre-IPO investor briefings and anchor investor allocations

Types of investors who can bring claims:
• Retail investors who subscribed in the IPO based on the prospectus
• Institutional investors (FIIs, domestic mutual funds, insurance companies) who subscribed during book-building
• Anchor investors who subscribed based on the draft red herring prospectus (DRHP) or final prospectus
• Secondary market investors who purchased shares post-listing in reliance on prospectus representations (in some jurisdictions)

👥

Defence Costs — Legal Protection from Day One

Securities claims are expensive to defend — even meritless claims generate substantial legal costs. POSI covers all reasonable defence costs from the point of claim:

What defence costs cover:
• Solicitors' and barristers' fees for defending SEBI enforcement proceedings, NCLT proceedings, stock exchange grievance proceedings, and civil court litigation
• Costs of responding to SEBI show-cause notices and summons
• Expert witness fees — financial economists, accounting experts, securities market experts
• Forensic accountant costs for reconstructing financial statements or analysing disclosures
• Costs of engaging independent directors and advisors in connection with the claim
• Travel and logistical costs of defending claims in multiple forums
• Costs of internal investigation to assess the merits of claims

Why defence costs coverage is critical even for meritless claims:
Most securities claims following an IPO are initially speculative — the claimant has bought shares that declined in value and alleges prospectus misrepresentation. Many such claims are ultimately unsuccessful. But defending them is expensive: a single SEBI enforcement proceeding can generate legal costs of ₹1–3 crore over 2–3 years; a full NCLT or High Court action defending a class of investors can cost ₹5–15 crore. POSI covers these defence costs from the moment the claim or investigation begins — protecting directors' personal assets from legal cost exposure even before the claim is resolved.

🏛

Underwriter & Book-Running Lead Manager Exposure

The investment banks (BRLMs — Book-Running Lead Managers) that manage an IPO carry significant prospectus liability as co-signatories of the offering documents:

Why BRLMs need POSI coverage:
• BRLMs conduct due diligence on the issuer and are responsible for the accuracy of prospectus disclosures. Any material misrepresentation that slipped through their due diligence creates potential liability
• BRLMs sign the prospectus alongside the issuer, making them joint signatories and co-responsible for prospectus content
• Investor claims may be directed against BRLMs as well as the issuer — particularly where investors allege that the BRLM's due diligence was inadequate
• SEBI enforcement action has increasingly focused on the quality of BRLM due diligence following high-profile IPO failures

POSI covers underwriter exposure arising from:
• Actual or alleged untrue or misleading statements in the prospectus that the underwriter was responsible for verifying
• Claims that the underwriter's due diligence was inadequate or negligent
• SEBI investigation and enforcement relating to the underwriter's role in the offering
• Third-party claims from investors who suffered losses in reliance on the prospectus that the underwriter helped prepare

Separate POSI for underwriters: While the issuer's POSI can extend to cover underwriter exposure, some BRLMs purchase their own separate POSI to ensure that their coverage is not shared with the issuer and is not subject to the same policy limits — particularly where the BRLM manages multiple IPOs in the same policy year.

⚖️

Selling Shareholder & Controlling Shareholder Liability

One of the most important and often overlooked components of POSI is the coverage for selling shareholders — particularly critical in IPOs with large Offer for Sale (OFS) components:

Who are selling shareholders in an IPO?
Promoter shareholders selling a portion of their holdings through the OFS component of the IPO
Private equity and venture capital investors exiting their investment through the IPO — the typical exit mechanism for PE/VC-backed companies going public
Strategic investors and pre-IPO shareholders monetising their holdings through the OFS
Employee shareholders selling ESOP shares through the IPO

Why selling shareholders need POSI:
Selling shareholders who sign or are associated with the prospectus carry liability for its contents. If the prospectus contains misrepresentations and investors sue, selling shareholders face the same claims as the company's directors — and their personal assets are at risk. For a PE fund that has exited ₹500 crore through an IPO OFS and receives an investor claim for ₹100 crore 3 years later, the fund's managing partners face significant personal and fund-level liability. POSI's selling shareholder coverage provides specific protection for this exposure.

Post-exit liability — a critical risk: PE and VC investors who have fully exited after the IPO and have no further involvement with the company can still be named in investor claims arising from the prospectus — years after they have received their exit proceeds. POSI's up-to-6-year policy period specifically addresses this post-exit liability risk that many PE exits overlook.

IPO · FPO · QIP · Rights Issue · OFS · Private Placement — Which Offerings Need POSI

Types of Securities Offerings Covered by POSI

POSI is designed for any capital market transaction involving the publication of an offering document. The coverage scope extends across the full range of equity and debt capital market offerings.

📈

Securities Offering Types — POSI Applicability Guide

Offering TypeDescriptionPOSI ApplicabilityKey Risk
Initial Public Offering (IPO)First listing on NSE/BSE — fresh issue + OFS component. DRHP filed with SEBI; full prospectus filed at listing.Primary use case for POSIHighest risk — first-time public disclosure; extensive mandatory disclosures; widest investor base; longest tail risk
Follow-on Public Offer (FPO)Additional equity issuance by an already-listed company through a fresh issue or OFS to public investors.Strongly recommendedIncremental prospectus liability; existing shareholders may compare FPO disclosures with prior statements
Qualified Institutional Placement (QIP)Placement of equity shares by a listed company exclusively to Qualified Institutional Buyers (QIBs) under SEBI (ICDR) Regulations, Chapter VI.Recommended — often overlookedInstitutional investors have resources and sophistication to pursue claims; placement memorandum creates prospectus-like liability
Rights IssueOffering of additional shares to existing shareholders in proportion to their current holdings, at a discount to market price.ApplicableRights issue letter of offer creates prospectus liability; existing shareholders are well-positioned to compare current vs prior disclosures
SME IPO / Emerge PlatformIPO of SME companies on NSE Emerge or BSE SME platforms under relaxed eligibility criteria and simplified disclosures.Applicable — often underinsuredSME directors often unaware of personal prospectus liability; smaller issue size does not reduce director liability exposure
Private Placement / Pre-IPOPlacement of securities to a defined set of investors (typically institutional) on a private basis, accompanied by an information memorandum.ApplicablePrivate placement memorandum creates liability for misrepresentations; sophisticated investors are better positioned to litigate
NCDs / Debt OfferingsPublic or private issuance of Non-Convertible Debentures (NCDs) or bonds through a prospectus or information memorandum.ApplicableNCD prospectus creates same liability as equity prospectus; debenture holders have fixed-income expectations and may litigate aggressively on default
📈

India IPO Market Context — Why POSI Demand Is Growing

India's primary market has witnessed extraordinary activity: FY2024–25 saw over 90 mainboard IPOs raising approximately ₹1.6 lakh crore — including landmark listings like Hyundai India (₹27,870 crore), NTPC Green Energy (₹10,000 crore), and several other ₹5,000 crore+ transactions. The SME platform saw over 200 IPOs in the same period. Retail investor participation has reached 9+ crore demat accounts. Post-listing scrutiny of prospectus disclosures by SEBI, media, and investors has intensified markedly. Several high-profile IPOs from 2021–2023 that listed at a premium but subsequently declined sharply in price triggered investor complaints and media scrutiny of prospectus disclosures — exactly the environment where POSI claims emerge. The frequency and quantum of potential securities litigation in India's capital markets makes POSI no longer optional for significant offerings.

Who Is Covered Under a POSI Policy — Insured Parties & Their Specific Exposures

Insured Parties — Who Is Protected by POSI

POSI is distinguished from standard D&O by its breadth of insured parties — covering not just the company and its board but every party who has signed or is associated with the prospectus and carries prospectus liability.

🏛

The Issuing Company

The company making the public offering is a primary insured under POSI. The company's liability arises from:

• Entity-level prospectus liability — the company is primarily responsible for the accuracy of its prospectus
• Regulatory enforcement — SEBI and NCLT proceedings against the company as issuer
• Investor class action — collective investor claims against the company for prospectus misrepresentation
• Indemnification obligations to directors — many companies contractually commit to indemnify their directors against securities claims; POSI covers this obligation at the company level

POSI vs D&O for the company:
Company-level securities claims may be covered under the company reimbursement section of a D&O policy, but standard D&O typically has limitations on securities claim coverage that POSI addresses specifically. For major offerings, companies prefer to have a dedicated POSI policy rather than rely on the D&O policy's potentially limited and contested securities coverage.

👥

Directors, Officers & Employees

Every individual who signs or is formally associated with the prospectus carries personal prospectus liability:

Who is personally liable under Indian law:
Under Section 34, 35, and 36 of the Companies Act 2013 (civil liability for misstatements in prospectus) and SEBI (ICDR) Regulations:
Managing Director / CEO: Signs the prospectus; carries primary management responsibility for its contents
CFO / Finance Director: Responsible for financial disclosures in the prospectus; faces specific liability for financial misstatements
All other Directors (including independent directors): Sign the prospectus; carry liability proportionate to their knowledge and role
Company Secretary: Formally associated with the prospectus filing and corporate governance disclosures
Other Senior Officers who are formally named or associated with the offering

Personal liability — why it is alarming for directors:
Section 35 of the Companies Act 2013 imposes civil liability for misstatements in the prospectus on every person who signed the prospectus — unless they can prove they had reasonable grounds to believe the statement was true. This reversal of the burden of proof means that a director who signed the prospectus must actively prove they were NOT negligent. Without POSI, each director faces personal liability — potentially exceeding their personal net worth — from investor class actions following an IPO where post-listing performance has disappointed.

⚖️

Underwriters & BRLMs

The Book-Running Lead Managers (BRLMs) — the investment banks that structure and manage the IPO — face significant exposure as co-signatories and due diligence parties:

• BRLMs sign the prospectus alongside the company's directors
• BRLMs are required to conduct and certify due diligence on the issuer's disclosures
• SEBI has powers to take enforcement action against BRLMs for inadequate due diligence
• Investor claims can name BRLMs alongside the issuer — particularly where the BRLM's due diligence process is alleged to have been inadequate

SEBI's increasing scrutiny of BRLMs:
SEBI has in recent years issued show-cause notices and imposed penalties on BRLMs for failures in IPO due diligence — including failures to identify and disclose material litigation, related-party transactions, and financial misstatements. This regulatory enforcement trend has significantly increased the personal liability awareness of BRLM partners and senior bankers who lead IPO transactions. Many leading investment banks now require issuer POSI coverage for their own protection as a condition of accepting an IPO mandate.

💵

Controlling & Selling Shareholders

Promoters, PE funds, VC investors, and other selling shareholders who participate in the OFS component face prospectus liability that persists long after their exit:

PE/VC fund managers' personal exposure:
Where a PE or VC fund is a selling shareholder in an IPO, the fund's general partners or managing partners who sign or are associated with the prospectus on behalf of the fund carry personal liability in addition to the fund entity's liability. Post-IPO investor claims can be directed personally against these individuals years after they have received their exit proceeds and moved on to new investments.

Lock-in expiry claims:
A common pattern of securities litigation follows lock-in expiry — when promoters or pre-IPO shareholders are released from their lock-in obligation and sell shares, a subsequent stock price decline may trigger investor claims alleging that the original prospectus overstated the company's prospects. These claims are directed at the original signatories of the prospectus, not the secondary market sellers.

POSI for PE/VC exits — a growing requirement:
Several large PE and VC funds active in India now require POSI as a standard requirement for IPO exits, protecting their limited partners and managing partners from the long-tail prospectus liability that could outlast the fund's investment period. This is particularly important for fund GPs who personally signed the prospectus on behalf of the fund.

Which Companies and Transactions Need POSI

Who Needs POSI Insurance?

POSI is relevant for any company making a public or private offering of its securities — but certain transactions create particularly acute prospectus liability exposures where POSI is virtually essential.

📈

Primary Market Transactions

  • Companies filing for IPO on NSE/BSE mainboard:The highest-risk category for prospectus liability. Mainboard IPOs raise large amounts (minimum ₹10 crore issue size, typically ₹100 crore+), involve SEBI scrutiny of the DRHP, attract broad retail investor participation, and are extensively covered by financial media. Any post-listing underperformance triggers investor scrutiny of prospectus disclosures. POSI is strongly recommended for every mainboard IPO, with coverage limits calibrated to the issue size and investor class composition.
  • PE-backed and VC-backed IPOs with large OFS:IPOs where a significant proportion of the offering is an Offer for Sale (OFS) by PE/VC investors create specific risks: investors may allege that the OFS was motivated by insider knowledge of future underperformance; the selling shareholders retain liability post-exit; and the IPO narrative (growth story built by PE investors over several years) is under particularly intense scrutiny. POSI for these transactions should specifically include adequate selling shareholder coverage for the PE/VC funds and their GPs.
  • Companies in high-scrutiny sectors:Certain sectors attract heightened investor and regulatory scrutiny of prospectus disclosures — fintech and payment companies (business model sustainability), new-age technology companies (path to profitability), healthcare companies (clinical outcomes and regulatory compliance), real estate companies (project completion and revenue recognition), and companies with complex related-party structures. POSI for these transactions should have higher limits and ensure comprehensive coverage of the specific risk factors that are most likely to be the subject of investor challenges.
  • SME IPOs on NSE Emerge / BSE SME:SME promoters and directors are often unaware of their personal prospectus liability. The simplified disclosure regime for SME IPOs does not reduce director liability — a director who signs an SME prospectus has the same personal liability as a mainboard IPO signatory. SME promoters with all their wealth tied up in the business are particularly vulnerable to personal liability claims. SME POSI at appropriate limits for smaller transactions is a risk management essential that very few SME IPO companies currently arrange.
💵

Capital Market Participants & Advisors

  • Investment banks (BRLMs) for each IPO mandate:Leading investment banks — Kotak Mahindra Capital, Axis Capital, ICICI Securities, Goldman Sachs India, JP Morgan India, and others — each manage multiple IPOs per year and carry cumulative prospectus liability across their entire BRLM mandate portfolio. Several BRLMs have implemented requirements for issuers to take POSI that covers BRLM exposure as a condition of accepting an IPO mandate. BRLMs should also consider their own standalone POSI coverage for transactions where the issuer's POSI may have insufficient limits.
  • Companies planning FPOs, QIPs, or Rights Issues:Already-listed companies making secondary offerings face prospectus liability for the incremental disclosures in the FPO/QIP/rights issue document, in addition to the enhanced scrutiny that existing shareholders apply to new disclosures by reference to prior company communications. POSI for secondary offerings protects against claims that the new offering document's disclosures were inconsistent with or materially omitted information relative to the company's prior public disclosures.
  • Companies with large international investor bases:Indian companies that list on Indian exchanges but have significant international institutional investors (FIIs, global funds) face an additional complexity — international investors may seek to bring claims in overseas jurisdictions under local securities laws. POSI can be structured to cover international securities claims arising from the same prospectus offering, providing a global protection framework.
  • Serial acquirers and corporate restructurers:Companies that grow through acquisitions and then list, or that undergo significant corporate restructuring before an IPO, face specific risk that pre-listing transactions are inadequately disclosed in the prospectus. POSI for these transactions should specifically cover the liability arising from disclosures about pre-IPO acquisitions, restructuring transactions, and the valuation basis for pre-listing corporate actions.
  • NCD / debt issuers with public subscriptions:Companies issuing Non-Convertible Debentures (NCDs) or corporate bonds through public subscriptions prepare an offer document that creates prospectus-equivalent liability. If the company subsequently defaults on NCD repayment, debenture holders may allege that the offer document misrepresented the company's financial health or repayment capacity. POSI for debt offerings protects the company and its directors against these post-default investor claims.

How POSI Claims Arise and Are Managed

Claim Process — POSI Insurance

POSI claims are complex, multi-year legal proceedings that require early notification and coordinated management across regulatory, civil, and company law forums. The insurer's specialist securities litigation team plays a central role in claim management.

🚨

Step 1 — Claim Triggers & Immediate Notification

A POSI claim can be triggered by any of the following events — notification to the insurer should occur at the earliest opportunity:

Common POSI claim triggers:
SEBI show-cause notice or examination: SEBI initiates an examination of the IPO prospectus disclosures, typically following investor complaints or post-listing price decline
Stock exchange investor grievance: A formal investor complaint filed with NSE or BSE regarding prospectus misrepresentation
NCLT application: An investor or creditor files an application before the National Company Law Tribunal alleging prospectus misrepresentation or fraud
Civil court claim: A civil suit filed in the High Court by one or more investors seeking damages for prospectus misrepresentation
Criminal complaint: A police or SFIO complaint alleging fraudulent prospectus misrepresentation (Note: criminal fines and penalties may not be covered under POSI, but defence costs in criminal proceedings typically are)
Media investigation: Significant media coverage of alleged prospectus inaccuracies that is likely to trigger regulatory or investor action
Notice from a large institutional investor: A formal legal notice from an anchor investor or institutional investor claiming prospectus misrepresentation

Timing of notification: Notify Probitas (022 4302 0000) at the earliest sign of any of the above — even before a formal claim is filed. Early notification preserves coverage and activates the insurer's specialist securities litigation team.

📋

Step 2 — Claim Assessment & Legal Defence

The insurer appoints specialist securities litigation counsel to assess and manage the claim:

Initial assessment:
• Review the prospectus in detail to identify the specific representations that are the subject of the claim
• Assess the merits of the claim — whether the challenged disclosure was materially inaccurate or misleading
• Identify all insured parties who are named or likely to be named in the claim
• Review the applicable SEBI regulations and Companies Act provisions
• Assess the likely quantum of the claim (investor losses, legal costs)

Legal defence strategy:
• Engage specialist securities litigation counsel (typically from firms with capital markets and SEBI regulatory expertise)
• Prepare the factual and legal basis for defending the specific allegations
• Manage all insured parties' defences in a coordinated manner (recognising that different insured parties — the company, individual directors, BRLMs — may have different interests that need to be carefully managed)
• Engage with SEBI, stock exchanges, NCLT, or courts as required
• Consider and advise on settlement where appropriate

Documentation required:
• Copy of the prospectus and all supplementary/marketing materials
• Copies of all claim notices, SEBI correspondence, court filings
• Evidence of pre-IPO due diligence materials
• Board minutes and management records relevant to prospectus preparation
• Post-IPO financial performance data

Step 3 — Settlement or Verdict

POSI claims are typically resolved through one of three outcomes:

1. Successful defence: The claim is dismissed or SEBI/NCLT proceedings are closed without adverse findings. POSI covers all legal defence costs incurred in achieving this outcome.

2. Negotiated settlement: The parties agree to a commercial settlement of the investor claim — typically at a discount to the theoretical maximum investor loss. POSI covers the settlement amount (subject to policy limit) and all legal costs of negotiating and documenting the settlement.

3. Adverse judgment or award: Where a court, NCLT, or regulatory authority makes an adverse finding and orders compensation to investors, POSI covers the compensation amount and any associated legal costs (subject to the policy limit).

The long timeline of POSI claims:
POSI claims are not resolved quickly. SEBI enforcement proceedings can take 2–4 years. NCLT proceedings can extend to 3–7 years. Civil court proceedings can take even longer. The up-to-6-year POSI policy period reflects this reality — the policy must remain in force for the full litigation duration. Where claims arise late in the policy period, the insurer should be notified promptly to preserve coverage.

Probitas manages the claim notification, documentation, and insurer liaison throughout the POSI claim lifecycle. Contact 022 4302 0000.

Key Exclusions Under POSI

Key Exclusions

POSI exclusions are focused on specific conduct categories and pre-existing circumstances. Understanding them ensures that the insured understands the boundaries of coverage at the time of placing the policy.

❌ Prior Claims & Known Circumstances

Claims or circumstances that were known before the policy was placed are excluded. Any existing investor complaints, SEBI investigations, or litigation relating to the company or its directors that pre-date the POSI policy must be disclosed at underwriting. Failure to disclose known circumstances is material non-disclosure that can void coverage.

❌ Bodily Injury & Property Damage

Physical injury to persons or damage to property is excluded from POSI (as with all financial lines policies). POSI covers financial and reputational losses arising from securities claims — not physical harm. Physical injury or property damage claims require general liability or other appropriate coverage.

❌ Dishonest or Fraudulent Acts

Deliberate fraud, intentional misrepresentation, or dishonest acts committed by the insured are excluded. POSI covers claims arising from alleged (even unproven) misrepresentation — but if a court or regulatory authority finally determines that the misrepresentation was deliberate and fraudulent, coverage for the perpetrators may be excluded. Defence costs are typically covered until such a final determination is made.

❌ Major Shareholder Exclusion

Claims brought by major shareholders (typically defined as shareholders holding above a threshold percentage — commonly 5% or more of the company's shares) against the company may be excluded or subject to specific conditions. This exclusion addresses the concern that controlling shareholders could effectively "self-deal" through insurance by bringing claims against the company they control.

❌ Pollution Liability

Environmental liability arising from the company's operations is excluded from POSI. If a securities claim is based on alleged misrepresentation of the company's environmental liability (rather than pollution liability itself), this may be covered — but direct environmental cleanup liability is not a POSI coverage.

❌ Criminal Fines & Penalties

Criminal fines and penalties imposed on insured persons found guilty of criminal securities fraud or securities law violations are not insurable in India and are therefore excluded. Legal defence costs in criminal proceedings are typically covered (subject to the policy terms), but any fine ultimately imposed following criminal conviction is excluded.

❌ Conduct After Policy Period

Securities claims arising from misrepresentations or conduct that occurred after the POSI policy period ended are not covered. POSI is a transaction-specific policy tied to the specific offering — it covers claims arising from that offering's prospectus, not from subsequent corporate disclosures or conduct.

❌ Uninsured Insured Persons

Claims between insured parties — for example, one director suing another director over prospectus misrepresentation liability — may be excluded or subject to specific conditions. Cross-claims between insured parties raise complex conflict-of-interest issues that the policy may address through specific conditions.

📋

Important Disclaimer

POSI is a specialist financial lines product requiring individual underwriting assessment for each transaction. Coverage terms, insured parties, policy period, limits, retentions, and exclusions are agreed at the time of placing the policy for each specific offering. This page provides general guidance based on the insurer's POSI product; the specific policy wording governs coverage in all cases. POSI placement must be arranged before or at the time of the offering — it cannot be placed retrospectively after claims have arisen. Probitas Insurance Brokers Pvt. Ltd. · IRDAI Lic. No. 528.

POSI / IPO Insurance Questions

Frequently Asked Questions

This is the most common question from companies preparing for an IPO. The short answer: D&O and POSI serve different purposes and POSI fills critical gaps that D&O does not address. Standard annual D&O policies have several limitations in the IPO context: (1) Securities claim coverage in standard Indian D&O policies is often limited and subject to conditions that may not be clearly satisfied by prospectus liability claims — the policy wording for securities liability varies significantly between D&O policies; (2) A large securities class action arising from an IPO can deplete the entire D&O policy limit, leaving the company's directors exposed for all other D&O claims during that policy year for entirely unrelated matters (employment claims, corporate governance disputes, regulatory investigations); (3) Standard D&O does not provide specific coverage for underwriter (BRLM) exposure — BRLMs are typically third parties not covered under the company's D&O; (4) D&O policies are annual policies that must be renewed each year — if the D&O policy is not renewed (due to insurer pullout, premium increase, or company financial difficulties), the multi-year tail of IPO securities liability is uninsured; (5) POSI's up-to-6-year policy period provides certainty of coverage for the full litigation tail from a single premium payment. The two products work best together: POSI ring-fences the IPO-specific securities exposure, while the D&O policy provides ongoing protection for all other director and officer liability. Most sophisticated companies and all major investment banks require both.
Yes — absolutely. Post-listing performance at the time of the IPO is irrelevant to prospectus liability, which is determined by what was in the prospectus and whether it was accurate, not by where the stock trades on listing day. Securities claims following an IPO typically arise 12–36 months after listing — when post-IPO quarterly and annual results begin to show actual performance against the projections and narrative in the prospectus. An IPO that lists at 50% premium and then declines significantly over the following 12–18 months as business realities diverge from prospectus projections is precisely the scenario that generates the most intense investor scrutiny of the prospectus. Many of India's high-profile 2021–2022 "new age" IPOs that listed at significant premiums subsequently declined sharply, triggering investor complaints and SEBI scrutiny of their prospectus disclosures. The POSI policy is priced at the time of the IPO and cannot be purchased retrospectively once claims begin to emerge. The time to buy POSI is before the IPO — not after performance has deteriorated. A listing-day premium gives no comfort regarding prospectus liability for the next six years.
PE and VC funds exiting through an IPO OFS face a distinct and sometimes underestimated liability exposure. As selling shareholders, your fund (and potentially your fund's managing partners who sign or represent the fund in the IPO process) carry liability for prospectus misrepresentations — not just for the OFS-specific disclosures but for the entire prospectus. Your liability persists after you have fully exited: a company whose prospectus you signed and whose shares you sold through OFS can be the subject of investor claims directed against you years after you have received your exit proceeds and reinvested them in new funds. There are three specific scenarios PE fund managers should understand: (1) Lock-in expiry claims — when selling shareholders are released from post-IPO lock-in, subsequent price declines can trigger allegations that the original prospectus overstated the company's prospects; (2) Post-exit performance claims — if the company underperforms the projections implicit in the IPO prospectus, investors may allege that the PE fund's exit was motivated by knowledge of future underperformance; (3) Due diligence claims — investors may allege that the PE fund's long-term involvement with the company meant it had (or should have had) knowledge of issues not disclosed in the prospectus. POSI with selling shareholder coverage — placed at the time of the IPO — specifically protects against all these scenarios, covering your defence costs and liability exposure for up to six years from the IPO. Most sophisticated PE houses globally now include POSI as a standard part of their IPO exit documentation. Call Probitas on 022 4302 0000 to discuss POSI for your specific transaction.
This is one of the most commercially compelling aspects of POSI for CFOs and finance directors planning an IPO. Accounting rules — specifically Ind AS 32 and Ind AS 109, as interpreted in the context of equity capital-raising transactions — may allow the POSI premium to be treated as a direct cost of the equity offering and netted against the proceeds, rather than being expensed through the profit and loss account. The rationale: POSI is an incremental cost directly attributable to the capital-raising transaction (similar to investment banking fees, legal costs, filing fees, and listing costs that are capitalised against offer proceeds). If this treatment is available for a specific transaction, the POSI premium has zero impact on the company's reported profit — it reduces the net proceeds of the IPO on the balance sheet. This makes POSI economically very attractive: the financial statement impact is identical to paying additional investment banking fees. The actual accounting treatment must be confirmed with the company's auditors and the transaction's reporting accountants before the IPO — accounting rules are complex and fact-specific. However, many Indian companies have successfully capitalised POSI premiums against IPO proceeds. This should be discussed with Probitas and the auditors as part of pre-IPO planning, well in advance of the DRHP filing.
POSI claims in India have historically been less frequent than in mature markets like the US (where securities class actions are extremely common) — but this is changing rapidly. The key triggers and trends in India: (1) SEBI enforcement actions — SEBI has increasingly investigated post-IPO cases where companies' actual performance diverged materially from prospectus disclosures. SEBI can initiate examination proceedings suo motu or following investor complaints, and these proceedings generate significant legal costs for the insured regardless of outcome; (2) Investor complaints to stock exchanges — NSE and BSE have investor grievance mechanisms that handle IPO-related complaints; a pattern of complaints about the same issue can trigger formal proceedings; (3) NCLT applications — investors can apply to the NCLT under the Companies Act for relief against prospectus misrepresentation; these proceedings are time-consuming and expensive to defend; (4) Media pressure — investigative financial journalism has increasingly targeted post-IPO companies whose performance has underperformed prospectus projections, generating reputational pressure and potential regulatory scrutiny; (5) SFIO investigations — the Serious Fraud Investigation Office (SFIO) has investigated several post-IPO situations involving alleged misrepresentation. The 2021–2023 period of India's tech IPO boom, followed by sharp corrections in several new-age listed companies, has significantly increased the real and perceived risk of POSI claims in India. Given the 2–6 year lag between IPO and claim, the full impact of the 2021–2023 boom period on Indian POSI claims is still emerging.
Yes — QIPs (Qualified Institutional Placements) create similar prospectus liability to IPOs and warrant POSI, though this is frequently overlooked by already-listed companies undertaking QIPs. In a QIP, the company prepares a detailed Placement Memorandum that contains representations about the company's financial condition, business prospects, and use of proceeds — very similar in structure and legal liability to an IPO prospectus. QIBs (Qualified Institutional Buyers) who subscribe in a QIP are large sophisticated investors — mutual funds, insurance companies, FIIs, banks — with the financial resources and legal sophistication to pursue claims if the placement memorandum contained material misrepresentations. If the QIP proceeds are used for an acquisition or expansion that subsequently fails, or if post-QIP financial performance materially underperforms the placement memorandum's projections, QIB investors may allege misrepresentation. SEBI has enforcement powers over QIP placement memoranda similar to those for IPO prospectuses. The relative underuse of POSI for QIPs in India appears to be a gap in awareness rather than genuine risk assessment. Any QIP raising more than ₹50 crore should seriously consider a transaction-specific POSI. Contact Probitas on 022 4302 0000 for a QIP-specific POSI discussion.
Management Liability Insurance (which includes D&O, Employment Practices Liability, and Crime coverages) and Errors & Omissions (E&O) / Professional Indemnity insurance are both related but different from POSI in important ways. D&O covers a broad range of management decisions and actions by directors and officers — employment disputes, corporate governance failures, regulatory investigations — on an annual basis across all the company's activities. It is not transaction-specific and its securities claim coverage is general and often contested. E&O / Professional Indemnity covers professional advice failures — it is most relevant for professionals who advised on the IPO (lawyers, accountants, independent valuation experts) for their errors in their advisory role. POSI is specifically and exclusively designed for securities offering transactions — it covers the prospectus liability arising from a specific capital-raising transaction, covers all signatories (company, directors, underwriters, selling shareholders) in relation to that specific document, lasts for up to 6 years without renewal risk, and can be capitalised against offer proceeds. The relationship between these products: D&O provides broad ongoing management liability protection; POSI provides deep, transaction-specific securities offering protection; E&O provides protection for the professional advisors. All three serve different purposes and the ideal programme for a company making a significant public offering includes all three, carefully coordinated to eliminate coverage gaps and avoid duplication.
POSI placement should begin well in advance of the IPO date — ideally at the same time the company engages BRLMs and begins DRHP preparation. Here is the practical timing: (1) Early stage (DRHP preparation): Engage Probitas to discuss POSI structure, potential insurer appetite, and indicative premium ranges. Discuss with auditors and transaction accountants whether POSI premium can be capitalised against offer proceeds. (2) DRHP filing stage: Submit the completed POSI application to insurers, including draft DRHP (or advanced draft), financial information, and details of all parties to be insured (company, directors, BRLMs, selling shareholders). Begin underwriting discussions. (3) SEBI observation letter stage: Finalise POSI terms once the DRHP is more settled and SEBI's key observations are known. (4) Pre-IPO opening: Bind coverage and receive policy documents before the IPO subscription period opens. POSI cannot protect against investor claims from subscriptions that occur before the policy is bound. Minimum lead time: 4–6 weeks from application to policy binding, though complex transactions with large selling shareholder structures may require 6–8 weeks. Engaging Probitas early ensures that POSI placement does not create a critical path delay in the overall IPO timeline. Call 022 4302 0000 to start the process.

Get Your POSI / IPO Insurance Quote

Public Offering of Securities Insurance — Transaction Enquiry

POSI is individually underwritten for each transaction. Share your offering details and Probitas will initiate the underwriting process with the insurer and other specialist market insurers.

📈 Issuer & Transaction Details

💵 Offering Details

By submitting you agree to our Privacy Policy and Terms & Conditions. POSI is a specialist financial lines product requiring individual underwriting assessment. Coverage terms, insured parties, limits, retentions, policy period, and premium are agreed at underwriting for each specific transaction. POSI must be placed before or at the time of the offering. Enquiries and confirmations: contact@takemyinsurance.com. Probitas Insurance Brokers Pvt. Ltd. · IRDAI Lic. No. 528.

📈 POSI — Ring-Fence Your IPO Securities Liability. Protect Directors, Underwriters & Selling Shareholders.

Prospectus Liability · Directors & Officers Defence · Underwriter Exposure · Selling Shareholder Cover · Defence Costs · Punitive Damages · Up to 6 Years · Premium Capitalisation — the insurer POSI for IPO, FPO, QIP, Rights Issue, Private Placement. Call 022 4302 0000.